<style>
    @font-face {
        font-family: 'MuseoSans_500';
        src: url('/fonts/MuseoSans_500-webfont.woff2') format('woff2'),
        url('/fonts/MuseoSans_500-webfont.woff') format('woff');
        font-weight: normal;
        font-style: normal;

    }
</style>

<!-----------------------------------------------------------------------------------
--
-- About Medlab
--
------------------------------------------------------------------------------------->
<div class="container medlab_panel_container">
    <div class="row">
        <div class="col-md-12 col-sm-12 col-xs-12">
            <!--
            -- About Medlab
            -->
            <div class="panel panel-primary medlab_panel">
                <div class="panel-heading medlab_panel_title">
                    Pharmaceutical Products In Development
                </div>
                <div class="panel-body medlab_panel_content">



                    <table class="table table-striped table-bordered table-responsive">
                        <tbody>
                        <tr>
                            <td style=min-width:50px><h3>NanaBis<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> In clinical Trial</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> Adjuvant and/or replacement therapy to opioids in advanced cancer pain</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S8 Specialist led.</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>NanaBidial<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> In clinical trial</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For CINV and seizures</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>NanoStat<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> In Bio-equivelance</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For the treament of elevated cholestrol</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>

                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>NanUlin<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> HREC aaproved trial forthcoming</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For type 2 diabetics</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>NanoTest<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> HREC approval trial forthcoming</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For increasing low testosterone levels in men</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>NanoCelle Fexodenadine<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> At Bench</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For convenience and faster absorption</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>NRGBiotic<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> In clinical trial [Phase 2]</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For TD patients on SSRI's</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>ORSBiotic<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> In trial development</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>T2Biotic<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> In clinical trial</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For treatment of pre-diabetic patients</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>
                        <tr>
                            <td style=min-width:50px><h3>MultiBiotic<sup>TM</sup></h3></td>
                            <td style=min-width:50px>
                                <p><font size="3" color="#7AA43F">Status:</font> In trial development</p>
                                <p><font size="3" color="#7AA43F">Purpose:</font> For the treament of Non Alcoholic Fatty Liver Disease (NAFLD) and NASH</p>
                                <p><font size="3" color="#7AA43F">Descriptive:</font> TO BE UPDATED SHORTLY</p>
                                <p><font size="3" color="#7AA43F">Proposed Regulatory Pathway:</font> Australian S4 , GP led</p>
                            </td>
                        </tr>




                        </tbody>
                    </table>




                </div>
                </div>

                </div>
            </div>
        </div>
